A Macro Fund’s Crypto Bet Puts On-Chain Options in the Spotlight
TREE NEWS reports: When Citrini Research, a macro shop previously skeptical of crypto, published its “Breaking The Wall” report on October 8, it didn’t just validate digital assets—it anointed a niche player. In its model portfolio, Derive’s $DRV received a 10% allocation, tied for the top weight with Lighter and Ether.fi. The market responded swiftly: $DRV climbed 44% in a week and roughly 260% in a month, settling near $0.55 and flirting with its all-time high of $0.5693.
The Valuation Math: Not Cheap
Derive is the dominant on-chain options protocol, capturing 91.7% of September’s $77.67 million in on-chain options premium volume. But its revenue is still modest. Over the past 30 days, users paid about $714,800 in fees, yielding $574,900 in net protocol income after market-maker rebates. Against a circulating market cap of $551 million and an FDV of $827 million, that annualizes to roughly 64x market cap/fees and 79.5x market cap/net income. In plain terms, buyers are paying about $80 for every $1 of annual profit—a rich multiple that demands future hypergrowth.
Bulls aren’t buying today’s cash flow; they’re betting on a Hyperliquid-style inflection. Hyperliquid saw fees surge 88x after a 10x volume increase. Derive’s nominal volume has already grown from $660 million to $5 billion in a year. If fees merely 5x from here, the valuation multiple compresses to about 16x—attractive for a revenue-generating crypto asset.
The Moat: A Monopoly Vacuum
Derive’s edge lies in margin efficiency: it allows options and hedges to be packaged together, reducing capital costs for large traders. Competitors are steering clear. Hyperliquid’s HIP-4 standard focuses on binary options, not the vanilla options that drive Derive’s business. Lighter, which has promised vanilla options, isn’t expected to deliver until late Q4 at the earliest. That leaves Derive with a rare window to entrench itself, especially as its V3 upgrade migrates settlement to Ethereum mainnet and opens cross-asset margin.
Buyback Boost—With a Catch
Starting October 14, Derive will raise its fee-funded buyback from 35% to 50%. That’s a structural bid, but higher prices mean fewer tokens retired per dollar. At $0.55, the same $350,000 monthly buyback absorbs roughly 600,000 tokens versus 2.3 million at $0.15. The real test: can that buy pressure offset profit-taking and token unlocks?
What to Watch
- Q4 revenue: September’s $700,000 is the baseline. If November and December break $1 million, the growth thesis is validated.
- Lighter’s delivery: If the rival ships vanilla options on time, Derive’s monopoly premium erodes.
- Token unlocks: Supply overhang could cap upside.
For now, the easy money has been made. A disciplined approach—building a small position and scaling in only on confirmed revenue acceleration—beats chasing a narrative that already prices in perfection.
